Furiex Pharmaceuticals (FURX) announces its PPD-10558 drug for treating statin-associated...

|About: Furiex Pharmaceuticals, Inc. (FURX)|By:, SA News Editor

Furiex Pharmaceuticals (FURX) announces its PPD-10558 drug for treating statin-associated myalgia "did not meet its primary efficacy endpoint" during Phase II trials. As a result, Furiex will discontinue further development work on PPD-10558. Shares are currently halted.